{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04300751",
            "orgStudyIdInfo": {
                "id": "55176"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01DA016718",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01DA016718"
                }
            ],
            "organization": {
                "fullName": "University of Kentucky",
                "class": "OTHER"
            },
            "briefTitle": "Alcohol and Opioids",
            "officialTitle": "Interactions of Alcohol and Opioids: Pharmacodynamic Effects",
            "therapeuticArea": [
                "Other"
            ],
            "study": "alcohol-and-opioids"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-03-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-03-05",
            "studyFirstSubmitQcDate": "2020-03-05",
            "studyFirstPostDateStruct": {
                "date": "2020-03-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-27",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Sharon Walsh",
                "investigatorTitle": "Director of the Center on Drug and Alcohol Research",
                "investigatorAffiliation": "University of Kentucky"
            },
            "leadSponsor": {
                "name": "Sharon Walsh",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will examine the effects of doses of alcohol/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction effects of these compounds."
        },
        "conditionsModule": {
            "conditions": [
                "Opioid Use",
                "Alcohol Drinking"
            ],
            "keywords": [
                "opioid",
                "opiate",
                "alcohol"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "This is a randomized, double-blind, double-dummy, placebo-controlled, within-subjects design",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 72,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Alcohol",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive experimental doses of active or placebo alcohol, p.o. Alcohol/placebo will be administered once per session.",
                    "interventionNames": [
                        "Drug: Alcohol"
                    ]
                },
                {
                    "label": "Opioid Agonist",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive non-therapeutic, experimental doses of an active opioid agonist or placebo. Active opioid agonist/placebo will be administered once per session and will be administered orally",
                    "interventionNames": [
                        "Drug: Opioid Agonist"
                    ]
                },
                {
                    "label": "Opioid Agonist/Alcohol Combination",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive non-therapeutic, experimental doses of active opioid/placebo in combination with experimental doses of active alcohol placebo. Opioid/placebo and alcohol/placebo doses will be administered once during each session. It is possible to receive both active drugs on the same day. Both opioid and alcohol doses will be administered orally.",
                    "interventionNames": [
                        "Drug: Alcohol",
                        "Drug: Opioid Agonist"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Alcohol",
                    "description": "Active alcohol or placebo, administered orally",
                    "armGroupLabels": [
                        "Alcohol",
                        "Opioid Agonist/Alcohol Combination"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Opioid Agonist",
                    "description": "Active opioid agonist or placebo, administered orally",
                    "armGroupLabels": [
                        "Opioid Agonist",
                        "Opioid Agonist/Alcohol Combination"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Subject-Rated Outcomes",
                    "description": "Participants will rate their subjective drug e\ufb00ects (ex: drug liking, high) on standardized VAS scales.",
                    "timeFrame": "These outcomes (visual analog scores, scale of 0-100) will be recorded prior to and in regular intervals after drug administration for the duration of the session (approx. 6.5 hours per session)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Oxygen Saturation",
                    "description": "Oxygen saturation (measured as a percentage) will be monitored throughout each session",
                    "timeFrame": "Oxygen saturation will be recorded prior to and in regular intervals after drug administration for the duration of the session (approx. 6.5 hours per session)"
                },
                {
                    "measure": "Change in Respiration Rate",
                    "description": "Respiration rate (number of breaths per minute)",
                    "timeFrame": "Respiration rate will be recorded prior to and in regular intervals after drug administration for the duration of the session (approx. 6.5 hours per session)"
                },
                {
                    "measure": "Change in Blood pressure",
                    "description": "Systolic and diastolic blood pressure (mm Hg)",
                    "timeFrame": "Blood pressure will be recorded prior to and in regular intervals after drug administration for the duration of the session (approx. 6.5 hours per session)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Healthy adults ages 21-55\n* Current non-medical use of opioids\n* Previous alcohol use\n\nExclusion Criteria:\n\n* Physical dependence on opioids, alcohol, or benzodiazepines/sedative/hypnotics\n* Seeking treatment for drug use\n* Significant medical problems",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Stevie Britch, PhD",
                    "role": "CONTACT",
                    "phone": "8592574581",
                    "email": "Stevie.Britch@uky.edu"
                },
                {
                    "name": "Paul Nuzzo, MA",
                    "role": "CONTACT",
                    "phone": "8593230002",
                    "email": "Paul.nuzzo@uky.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Sharon Walsh, PhD",
                    "affiliation": "University of Kentucky",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Kentucky",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40508",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paul Nuzzo, MA",
                            "role": "CONTACT",
                            "phone": "859-323-0002",
                            "email": "Paul.nuzzo@uky.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "We have no plans to share individual participant data with other researchers."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000428",
                    "term": "Alcohol Drinking"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004327",
                    "term": "Drinking Behavior"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3774",
                    "name": "Alcohol Drinking",
                    "asFound": "Alcohol Drinking",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7502",
                    "name": "Drinking Behavior",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000701",
                    "term": "Analgesics, Opioid"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009294",
                    "term": "Narcotics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "asFound": "Capecitabine",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                },
                {
                    "id": "M27371",
                    "name": "Opiate Alkaloids",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M12245",
                    "name": "Narcotics",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}